A Sub-Study of an investigator initiated and conducted, multicentre, international,
double-blinded, placebo-controlled, parallel-group, randomised controlled trial (TRIDENT) to
determine the effect of more intensive long-term blood pressure control, provided by a fixed
low-dose combination blood pressure lowering pill ("Triple Pill") strategy on top of standard
of care, for slowing memory decline as measured by Cambridge Neuropsychological Test
Automated Battery (CANTAB), in patients with a history of acute stroke due to intracerebral
haemorrhage (ICH).